← FDA Drug Approvals (Drugs@FDA)

DEFLAZACORT

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS INC · Approved 2026-10-19

Drug application

FDA Application #

ANDA217103

Application type

Abbreviated New Drug Application (Generic)

Brand name

DEFLAZACORT

Generic name

Deflazacort

Active ingredients

DEFLAZACORT

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

TEVA PHARMS INC

First approval

2026-10-19

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown